Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  LRP-1-targeted peptide-drug conjugate GRN1005
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
ANG1005 in Breast Cancer Patients With Recurrent Brain Metastases
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: ANG1005-CLN-04, NCI-2014-00443, NCT02048059
Start Over